In 1923 was created Battelle Memorial Institute, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Columbus.
The high activity for fund was in 2003. The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2007. The common things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 5 participants. Despite the Battelle Memorial Institute, startups are often financed by Pfizer. The meaningful sponsors for the fund in investment in the same round are TL Ventures, Richardson Capital, Merlin Biomed. In the next rounds fund is usually obtained by TL Ventures, Safeguard Scientifics, Reservoir Venture Partners.
Among the most popular portfolio startups of the fund, we may highlight Ventaira Pharmaceuticals. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Pharmaceutical, Therapeutics.
Related Funds
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Allonnia | $30M | 12 Jul 2023 | Boston, Massachusetts, United States | ||
| $20M | 17 Mar 2021 | Boston, Massachusetts, United States | |||
| $40M | 22 Oct 2020 | Boston, Massachusetts, United States | |||
Ventaira Pharmaceuticals | $22M | 20 Feb 2003 | Columbus, Ohio, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Allonnia | $30M | 12 Jul 2023 | Boston, Massachusetts, United States | ||
| $20M | 17 Mar 2021 | Boston, Massachusetts, United States | |||
| $40M | 22 Oct 2020 | Boston, Massachusetts, United States | |||
Ventaira Pharmaceuticals | $22M | 20 Feb 2003 | Columbus, Ohio, United States |
